Haploidentical Transplantation With CD3/CD19 Depleted Grafts in Patients With Hematologic Malignancies
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study the feasibility and Toxicity of allogeneic
haploidentical hematopoietic cell transplantation with CD3/CD19 depleted stem cells and a
dose reduced conditioning.